Aβ Conformation Dependent Antibodies and Alzheimer's Disease

Aβ Conformation Dependent Antibodies and Alzheimer's Disease

Soluble intermediates of the amyloid-β (Aβ) aggregation process are suggested to play a central role in the pathogenesis of Alzheimer’s disease (AD) by causing synaptic dysfunction and neuronal loss. In this thesis, soluble Aβ aggregates have been studied with...

Full description

Bibliographic Details
Main Author:	Sehlin, Dag
Format:	Doctoral Thesis
Language:	English
Published:	Uppsala universitet, Geriatrik 2010
Subjects:	Alzheimer's disease amyloid-beta protofibrils conformation monoclonal antibody ELISA MEDICINE MEDICIN
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-132736 http://nbn-resolving.de/urn:isbn:978-91-554-7949-7

Similar Items

Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
by: Söllvander, Sofia
Published: (2015)

Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
by: Stina Syvänen, et al.
Published: (2018-05-01)

Amyloid-β Protofibril Formation and Neurotoxicity : Implications for Alzheimer’s Disease
by: Johansson, Ann-Sofi
Published: (2007)

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2020-01-01)

SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease
by: Tobias Gustavsson, et al.
Published: (2020-09-01)

Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
by: Fadi Rofo, et al.
Published: (2021-09-01)

An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
by: Anna Lord, et al.
Published: (2009-12-01)

BETA AMYLOID POLYCLONAL ANTIBODY IMMUNOGENICITY AS EARLY DEVELOPMENT STUDY OF EARLY DIAGNOSIS FOR ALZHEIMER’S DISEASE
by: M. Rasjad Indra, et al.
Published: (2017-01-01)

Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration
by: Brian M. Whalen, et al.
Published: (2005-11-01)

Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta
by: Vitaly Vasilevko, et al.
Published: (2010-09-01)

Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
by: Kohyama K, et al.
Published: (2015-01-01)

Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
by: Krystal Herline, et al.
Published: (2018-06-01)

he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
by: Garrett S. Gibbons, et al.
Published: (2020-11-01)

Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
by: Marta Westwood, et al.
Published: (2015-07-01)

Modeling Amyloid-β Pathology in Alzheimer’s Disease Using the Arctic Mutation
by: Philipson, Ola
Published: (2010)

The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
by: Sofia Söllvander, et al.
Published: (2018-03-01)

Quantification of Alzheimer DiseaseAmyloid β Peptide 43 in Human BrainWith a Newly Developed Enzyme-LinkedImmunosorbent Assay (ELISA)
by: Nicklagård, Erik
Published: (2011)

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
by: Jinhua Wen, et al.
Published: (2021-09-01)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
by: Isabelle L. Sumner, et al.
Published: (2018-04-01)

Development of Antibody Arrays for Monoclonal Antibody Higher Order Structure Analysis
by: Xing eWang, et al.
Published: (2013-08-01)

Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer’s Disease
by: Zhi-Ting Sun, et al.
Published: (2021-04-01)

Albumin Alters the Conformational Ensemble of Amyloid-β by Promiscuous Interactions: Implications for Amyloid Inhibition
by: Huisi Xie, et al.
Published: (2021-02-01)

Amyloid Cascade Hypothesis Perspective on Alzheimer's Disease

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

In vivo amyloid-β imaging in the APPPS1-21 transgenic mouse model with a 89Zr- labeled monoclonal antibody.
by: Ann-Marie eWaldron, et al.
Published: (2016-03-01)

MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
by: G. V. Kuklina, et al.
Published: (2017-06-01)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
by: Garrett S. Gibbons, et al.
Published: (2019-03-01)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
by: Claudia Balducci, et al.
Published: (2019-07-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations
by: Zhiwei Liu, et al.
Published: (2019-04-01)

The situations and strategies of amyloid⁃β⁃directed passive immunotherapy for Alzheimer's disease
by: Ya LI, et al.
Published: (2019-12-01)

Dynamic Blood Concentrations of Aβ1–40 and Aβ1–42 in Alzheimer’s Disease
by: Yuan-Han Yang, et al.
Published: (2020-08-01)

Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
by: Dominik Röhr, et al.
Published: (2020-12-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

The role of astrocytes in amyloid production and Alzheimer's disease
by: Georgia R. Frost, et al.
Published: (2017-01-01)

Towards an early diagnosis of Alzheimer's disease: development of an ATR-FTIR biosensor for the detection of Abeta toxic conformations
by: Kleiren, Emilie
Published: (2013)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)